Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harrow (HROW) Gains from Sales and Divestitures: 2015-2025

Historic Gains from Sales and Divestitures for Harrow (HROW) over the last 11 years, with Sep 2025 value amounting to $1.6 million.

  • Harrow's Gains from Sales and Divestitures rose 401.45% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year increase of 401.45%. This contributed to the annual value of $327,998 for FY2024, which is 86.74% up from last year.
  • Latest data reveals that Harrow reported Gains from Sales and Divestitures of $1.6 million as of Q3 2025, which was down 0.00% from $1.6 million recorded in Q2 2025.
  • In the past 5 years, Harrow's Gains from Sales and Divestitures registered a high of $1.3 billion during Q3 2021, and its lowest value of $17,410 during Q1 2025.
  • Moreover, its 3-year median value for Gains from Sales and Divestitures was $283,389 (2024), whereas its average is $454,777.
  • Its Gains from Sales and Divestitures has fluctuated over the past 5 years, first skyrocketed by 2,571,871.95% in 2021, then plummeted by 99.98% in 2022.
  • Quarterly analysis of 5 years shows Harrow's Gains from Sales and Divestitures stood at $1.3 million in 2021, then plummeted by 81.40% to $237,098 in 2022, then fell by 25.92% to $175,643 in 2023, then soared by 86.74% to $327,998 in 2024, then surged by 401.45% to $1.6 million in 2025.
  • Its Gains from Sales and Divestitures was $1.6 million in Q3 2025, compared to $1.6 million in Q2 2025 and $17,410 in Q1 2025.